News Releases

Select year
Categories

myChoice HRD(TM) Test Identifies Breast Cancer Patients Likely to Respond to Platinum-Containing Therapies

Dec 10, 2015 | Products

Read more

Multiple Scientific Presentations at the San Antonio Breast Cancer Symposium Highlight the Clinical Utility of the Myriad myRisk(TM) Hereditary Cancer Gene Panel Test

Dec 09, 2015 | Products

Read more

United States Patent and Trademark Office Grants Patent for Vectra(R) DA

Dec 01, 2015 | Products

Read more

Myriad Will Present Eight Studies at the 2015 San Antonio Breast Cancer Symposium

Nov 17, 2015 | Products

Read more

Myriad RBM DiscoveryMAP(R) Technology Identifies Novel Biomarkers That May Predict Increased Risk of Cardiovascular Events in Patients With Diabetes

Nov 16, 2015 | Products

Read more

Crescendo Bioscience Announces That New Studies With Vectra(R) DA Data Will be Presented at the American College of Rheumatology 2015 Annual Meeting

Nov 07, 2015 | Products

Read more

Crescendo Bioscience Highlights New Studies With Vectra(R) DA That Will Be Presented at the American College of Rheumatology 2015 Annual Meeting

Oct 22, 2015 | Products

Read more

Myriad Will Highlight New Data on Its myRisk™ Hereditary Cancer Test at the National Society of Genetic Counselors Annual Conference

Oct 21, 2015 | Products

Read more

Myriad to Present New Data on Its myRisk(TM) Hereditary Cancer Test at the CGA-ICC Annual Meeting

Oct 09, 2015 | Products

Read more

Myriad Genetics to Highlight New Clinical Outcomes Data on myPath(R) Melanoma at the American Society of Dermatopathology Annual Meeting

Oct 08, 2015 | Products

Read more

Myriad Genetics and Tufts Health Plan Sign Agreement to Cover Prolaris(R) for Members With Localized Prostate Cancer

Oct 07, 2015 | Products

Read more

Myriad to Present Seven Studies at the ASHG Annual Meeting

Oct 05, 2015 | Products

Read more

Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting

Sep 24, 2015 | Products

Read more

Myriad Adds to Scientific Evidence for the myPlan(R) Lung Cancer Prognostic Test

Sep 09, 2015 | Products

Read more

Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting

May 29, 2015 | Products

Read more

Myriad Significantly Advances the myChoice(R) HRD(TM) Companion Diagnostic Test

May 29, 2015 | Products

Read more

Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer

May 15, 2015 | Products

Read more

Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting

May 13, 2015 | Products

Read more

Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting

May 07, 2015 | Products

Read more

Myriad and AstraZeneca Expand Research Collaboration on Lynparza

Apr 01, 2015 | Products

Read more

Myriad Announces Prolaris® Test Biopsy Results From EMPATHY-P Study at European Association of Urology Annual Meeting

Mar 20, 2015 | Products

Read more

Myriad and BioMarin Expand Collaboration to Evaluate myChoice HRD(TM) as a Companion Diagnostic for Talazoparib

Mar 17, 2015 | Products

Read more

Myriad RBM Launches New Immunoassay Services Based on the Ultrasensitive Simoa(TM) Platform

Mar 05, 2015 | Products

Read more

Myriad Publishes myPath(TM) Melanoma Pivotal Validation Study in the Journal of Cutaneous Pathology

Mar 04, 2015 | Products

Read more

Myriad RBM Joins Institut Pasteur in the Global Fight Against Tuberculosis

Jan 20, 2015 | Products

Read more

Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors

Jan 08, 2015 | Products

Read more